A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.

In all, it said it was now setting aside about $11bn (£8.8bn) to address the talc litigation. This is the third settlement offer Johnson & Johnson has put forward to try to address the claims from former customers,

J&J received a new chance to contest the scientific evidence linking talc to ovarian cancer in the centralized litigation in New Jersey federal court. The judge overseei

Johnson & Johnson will ask thousands of people suing over its allegedly tainted baby powder to vote for a settlement that would resolve all litigation for $11 billion — $2.1 billion more than the company offered last year.

The healthcare-products company plans to file a third bankruptcy case to resolve talc-related liabilities if enough injury claimants accept its offer first.

A subsidiary of Johnson & Johnson (J&J) is proposing to pay more than $6.5 billion to resolve nearly all the talc ovarian cancer lawsuits brought against the company. J&J said that the